Connect Biopharma Holdings Limited - American Depositary Shares — Cash Flow (NASDAQ:CNTB) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Cash from operating activities -85.47 M97.6 M47.9 M23.61 M 42.27 M Cash from investing activities 5.34 M82.03 M75.16 M3.45 M -7.7 M Cash from financing activities 206.42 M90 K246 K227 K 484 K Free cash flow -85.47 M97.6 M47.9 M22.86 M 41.54 M

Nouvelles

Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases Transcript

Cet analyste d'Immuneering commence la couverture avec une note optimiste; Voici les 5 meilleures initiations pour vendredi | Benzinga France

Connect Biopharma : action initiée avec une recommandation d’achat par BTIG

Connect Biopharma stock initiated with Buy rating at BTIG on respiratory drug potential

This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Connect Biopharma Hldgs (NASDAQ:CNTB), Immuneering (NASDAQ:IMRX)

H.C. Wainwright maintient sa recommandation d’achat sur Connect Biopharma avec un objectif de 7€

H.C. Wainwright reiterates Buy rating on Connect Biopharma stock at $7 target

Connect Biopharma Posts Q2 Revenue Drop

What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now?

Connect Biopharma stock rating reiterated as Outperform by Northland

Connect Biopharma appoints Jim Schoeneck to board of directors

Connect Biopharma appoints James A. Schoeneck to board of directors